bioRxiv Science⌕ Search

Biology subjects

Bamberger, T.

Publications and source records attributed to Bamberger, T..

5 recordsLinked to original sources

Phenotype-driven parallel embedding for microbiome multi-omic data integration

The human microbiome is widely recognized as a key determinant of health and disease, yet most reported links between observed microbial features and clinical outcomes remain descriptive and lack an integrated system-level perspective. Multi-omic studies of the microbiome, which jointly profile and analyze multiple molecular aspects of the microbiome via metagenomics, metabolomics, proteomics, and transcriptomics assays, offers a more comprehensive view of this system, with the potential to uncover how microbial communities and functions influence host physiology. However, integration of such multi-omic data remains challenging due to high dimensionality, major differences in data properties across omics, and the need to utilize and preserve omic-specific information. Embedding omic data in low-dimensional spaces offer a promising avenue to capture complex patterns, reduce noise, and improve downstream analysis, yet most embedding-based microbiome studies to date exhibited limited predictive power or relied on a single joint embedding of all omics thus failing to preserve omic-species properties. To address this, we introduce PAPRICA (Phenotype-Aware Parallel Representation for Integrative omiC Analysis), an encoder-decoder framework for microbiome multi-omic integration that embeds each omic into its own latent space while jointly modeling their relationships. The model consists of parallel autoencoders trained with a loss function that promotes three objectives: (1) accurate reconstruction of each omic, (2) alignment of samples across omics such that proximity in one latent space reflects proximity in the others, and (3) alignment with a phenotype space to capture variation associated with continuous outcomes, such as fecal calprotectin levels in IBD. The resulting models support cross-omic inference and phenotype prediction from the learned latent representations, and enables integration without collapsing data into a single space. This modeling approach thus preserves omic-specific signals while capturing phenotype-associated variation. We compared PAPRICA to four alternative models that represent successive advances in multi-omic integration architectures. We found that across two complementary tasks, predicting one omic profile from another and predicting a continuous phenotype from an input omic profile, our parallel autoencoder approach, and particularly the PAPRICA model, demonstrated better performance across three multi-omic datasets (the Franzosa IBD cohort, Lifelines DEEP and the Dog Aging Project Precision Cohort). Combined, these findings suggest that our embedding strategy effectively captures and balances omic-specific structure, cross-omic relationships, and phenotype-relevant signals across diverse datasets, offering a flexible, scalable framework for embedding complex multi-omic microbiome data and advancing our ability to gain new insights into host-microbiome interactions.

bioinformatics↗

Mapping the canine microbiome: Insights from the Dog Aging Project

Companion dogs (Canis lupus familiaris) offer a unique model for studying the gut microbiome and its relation to aging due to their cohabitation with humans, sharing similar environments, diets, and healthcare practices. Here, we present the Dog Aging Project (DAP) Precision cohort, the largest population-wide study of the canine gut microbiome to date. This cohort encompasses over 900 dogs of diverse breeds, environments, and demographics living across the United States. Coupling fecal shotgun metagenomic sequencing with comprehensive phenotypic and environmental surveys and clinical lab tests, we explore the intricate relationships between microbiome composition, aging, and key factors such as diet, health, and living conditions. Our analyses identify various factors associated with microbiome composition. In addition, we find a gradual shift in microbiome composition with age, which allows us to develop a novel metagenomics-based "clock" to predict biological aging based on microbial signatures. Overall, these findings provide an unprecedented and detailed understanding of the role the gut microbiome plays in our four-legged companions, offering both potential applications in veterinary medicine and an exciting model for aging research.

microbiology↗

Protein catabolites as blood-based biomarkers of aging physiology: Findings from the Dog Aging Project

Our understanding of age-related physiology and metabolism has grown through the study of systems biology, including transcriptomics, single-cell analysis, proteomics and metabolomics. Studies in lab organisms in controlled environments, while powerful and complex, fall short of capturing the breadth of genetic and environmental variation in nature. Thus, there is now a major effort in geroscience to identify aging biomarkers and to develop aging interventions that might be applied across the diversity of humans and other free-living species. To meet this challenge, the Dog Aging Project (DAP) is designed to identify cross-sectional and longitudinal patterns of aging in complex systems, and how these are shaped by the diversity of genetic and environmental variation among companion dogs. Here we surveyed the plasma metabolome from the first year of sampling of the Precision Cohort of the DAP. By incorporating extensive metadata and whole genome sequencing information, we were able to overcome the limitations inherent in breed-based estimates of genetic and physiological effects, and to probe the physiological and dietary basis of the age-related metabolome. We identified a significant effect of age on approximately 40% of measured metabolites. Among other insights, we discovered a potentially novel biomarker of age in the post-translationally modified amino acids (ptmAAs). The ptmAAs, which can only be generated by protein hydrolysis, covaried both with age and with other biomarkers of amino acid metabolism, and in a way that was robust to diet. Clinical measures of kidney function mediated about half of the higher ptmAA levels in older dogs. This work identifies ptmAAs as robust indicators of age in dogs, and points to kidney function as a physiological mediator of age-associated variation in the plasma metabolome.

systems biology↗

DNA methylation of transposons pattern aging differences across a diverse cohort of dogs from the Dog Aging Project

Within a species, larger individuals often have shorter lives and higher rates of age-related disease. Despite this well-known link, we still know little about underlying age-related epigenetic differences, which could help us better understand inter-individual variation in aging and the etiology, onset, and progression of age-associated disease. Dogs exhibit this negative correlation between size, health, and longevity and thus represent an excellent system in which to test the underlying mechanisms. Here, we quantified genome-wide DNA methylation in a cohort of 864 dogs in the Dog Aging Project. Age strongly patterned the dog epigenome, with the majority (66% of age-associated loci) of regions associating age-related loss of methylation. These age effects were non-randomly distributed in the genome and differed depending on genomic context. We found the LINE1 (long interspersed elements) class of TEs (transposable elements) were the most frequently hypomethylated with age (FDR < 0.05, 40% of all LINE1 regions). This LINE1 pattern differed in magnitude across breeds of different sizes- the largest dogs lost 0.26% more LINE1 methylation per year than the smallest dogs. This suggests that epigenetic regulation of TEs, particularly LINE1s, may contribute to accelerated age and disease phenotypes within a species. Since our study focused on the methylome of immune cells, we looked at LINE1 methylation changes in golden retrievers, a breed highly susceptible to hematopoietic cancers, and found they have accelerated age-related LINE1 hypomethylation compared to other breeds. We also found many of the LINE1s hypomethylated with age are located on the X chromosome and are, when considering X chromosome inactivation, counter-intuitively more methylated in males. These results have revealed the demethylation of LINE1 transposons as a potential driver of intra-species, demographic-dependent aging variation.

genomics↗

Aging at scale: Younger dogs and larger breeds from the Dog Aging Project show accelerated epigenetic aging.

Dogs exhibit striking within-species variability in lifespan, with smaller breeds often living more than twice as long as larger breeds. This longevity discrepancy also extends to health and aging-larger dogs show higher rates of age-related diseases. Despite this well-established phenomenon, we still know little about the biomarkers and molecular mechanisms that might underlie breed differences in aging and survival. To address this gap, we generated an epigenetic clock using DNA methylation from over 3 million CpG sites in a deeply phenotyped cohort of 864 companion dogs from the Dog Aging Project, including some dogs sampled annually for 2-3 years. We found that the largest breed size tends to have epigenomes that are, on average, 0.37 years older per chronological year compared to the smallest breed size. We also found that higher residual epigenetic age was significantly associated with increased mortality risk, with dogs experiencing a 34% higher risk of death for each year increase in residual epigenetic age. These findings not only broaden our understanding of how aging manifests within a diverse species but also highlight the significant role that demographic factors play in modulating the biological mechanisms underlying aging. Additionally, they highlight the utility of DNA methylation as both a biomarker for healthspan-extending interventions, a mortality predictor, and a mechanism for understanding inter-individual variation in aging in dogs.

genomics↗